Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder affecting children and adults. Recently, there has been growing interest in the potential role of diet in the ...

But does it cost too much?

Harrow, Inc. is rapidly evolving into a dominant US ophthalmic pharma player, with a 30-fold revenue increase since 2015 and ...

Many hospitalized adults could benefit from linkage to dental care. This article describes a planned study to refer inpatients to community dental providers. Objectives: Previous research suggests ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...

Epilepsy is one of the common disorders known to man, with early accounts of the disorder traced back to antiquity.1 It was ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...